Avenue Therapeutics Inc (ATXI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3110 -0.0190 (-5.76%) 03/28/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3110 unch (unch) 15:53 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Cash Flows From Operating Activities | |||||
Net Income | -11,618 | -7,602 | -3,603 | -4,127 | -3,465 |
Accounts receivable | -26 | -13 | 90 | N/A | N/A |
Other Working Capital | 12 | 838 | 408 | 63 | -20 |
Other Operating Activity | 5,394 | 5,204 | -4,491 | 637 | 612 |
Operating Cash Flow | $-6,238 | $-1,573 | $-7,596 | $-3,427 | $-2,873 |
Cash Flows From Investing Activities | |||||
Other Investing Activity | -2,000 | 0 | 0 | 0 | 0 |
Investing Cash Flow | $-2,000 | $N/A | $N/A | $N/A | $N/A |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 3,101 | 3,101 | 11,645 | N/A | N/A |
Common Stock Repurchased | N/A | N/A | -1,104 | N/A | N/A |
Other Financing Activity | 0 | 0 | 0 | -119 | 0 |
Financing Cash Flow | $3,101 | $3,101 | $10,541 | $-119 | $N/A |
Beginning Cash Position | 6,708 | 6,708 | 3,763 | 3,763 | 3,763 |
End Cash Position | 1,571 | 8,236 | 6,708 | 217 | 890 |
Net Cash Flow | $-5,137 | $1,528 | $2,945 | $-3,546 | $-2,873 |
Free Cash Flow | |||||
Operating Cash Flow | -6,238 | -1,573 | -7,596 | -3,427 | -2,873 |
Free Cash Flow | -6,238 | -1,573 | -7,596 | -3,427 | -2,873 |